Académique Documents
Professionnel Documents
Culture Documents
Introduction
without pre-existing access, treatment may be delayed by attempts at peripheral intravenous (IV)
access or the insertion of a central venous catheter (CVC). Delaying fluid resuscitation and
administration of antibiotics can adversely affect morbidity and mortality. Patients with severe
sepsis have hospital mortality rates between 18-50% with the average in the United States being
28% (Surviving Sepsis Campaign, 2012). According to the Surviving Sepsis Campaign Bundle,
within the first three hours of presentation of septic shock or severe sepsis the following are to be
completed: blood cultures prior to antibiotic administration, lactate level, administration of broad
2012). Intraosseous (IO) access is a quick and effective way to establish a means for blood
sampling, antibiotic and fluid administration without delaying treatment for IV or CVC access.
Major complications with IO insertions and use are extremely rare with low minor complication
rates. IO access is accepted standard practice in pediatric patients, however is underutilized in the
adult population.
The success of IO access in other emergent and non-emergent cases is well documented.
In the emergency room (ER), patients in sepsis, who do not have existing access, can greatly
benefit from the use of IO access to deliver fluids and medications quickly. Delaying treatment
for peripheral or central venous access has the potential to increase the risk of morbidity and
mortality and is unnecessary when IO access is readily available (Philips, L. et. al., 2010).
Currently, the sepsis bundle includes fluid resuscitation at 30mL/kg to be completed within the
IO ACCESS IN SEPTIC PATIENTS 3
first three hours of presentation but does not have any provisions for the use of IO access
Research Question
In adult septic shock patients treated in the emergency department (P), how does
intraosseous (IO) access for fluid resuscitation (I) compared to intravenous (IV) access (C) affect
Literature Review
IO access was utilized extensively during World War II after being introduced as a way to
perform transfusions as well as deliver medications and fluids (Day, 2011). After the
development of the plastic peripheral intravenous catheter, IO access research was limited until
the late 1970s (Day, 2011). IO access is currently routinely used and recommended for use in the
pediatric population as well as endorsed by the American Heart Association for routine use in
cardiac arrest patients and multiple professional societies recognize that intraosseous access
may provide significant time savings that could benefit patients in emergent situations by
decreasing the time required to achieve access and the time required to administer necessary
The military has provided more research in recent years to include case studies and level
I-II evidence as use of IO access has been essential for use in the Iraqi War Theater. Civilian data
regarding IO access is limited but includes level I-III evidence, primarily in regards to trauma
patients in the ED and hypovolemic states. As severe sepsis and septic shock are hypovolemic
Data gathered from the military in recent years includes hypovolemia secondary to
trauma with IO insertion being performed both pre-hospital and in the emergency department of
IO ACCESS IN SEPTIC PATIENTS 4
deployed medical facilities. Success rates for IO access were found to be between 85-97% with a
recent analysis of 1000 uses of IO access from a 7-year period between 2006 and 2013 during
combat operations in Afghanistan concluded that IO access has a valuable role in resuscitation of
the critical patient with low complications rates (Lewis, P. & Wright, C., 2015, p. 463). Literature
consistently demonstrates ease of use of IO devices and high success rates after minimal training
and education.
Regarding speed of insertion, with minimal training, IO is 6 minutes faster and easier to
achieve than central vascular access and requires less training (Joanne, 2015, P 172). Multiple
studies site a higher first time insertion success rate and faster procedure time with IO access
compared to CVC, however it should be noted that IO is not a replacement for CVC (Leidel,
2012, P 40). Definitive access will still need to be obtained within 24 hours as that is the limit
fracture, growth plate injury, infection, fat emboli, compartment syndrome, and osteomyelitis
(Phillips, 2011, P 87). Complications are short term and rare with limited evidence available
regarding long term complications of IO use. Contraindications to use include long bone
fracture, severe bone disease and femoral or saphenal venous cut-down in the same limb (Craiu,
2014).
One of the main benefits of utilizing IO access in hypovolemic and shock states is
because the IO space is not compromised during shock (Lowther, 2011, P 36). It should also be
noted that The International Liasion Committee on Resuscitation and the European Resuscitation
Counsel advocate for IO over CVC or endotracheal drug administration (Anson, 2014, P 1015).
IO ACCESS IN SEPTIC PATIENTS 5
Research data has shown consistently that administration of fluids and drugs is equal
when given either by IO or IV access. In some instances, data has shown that fluids and drugs
administered through the IO space reach the central circulation as quickly as central lines and
Many facilities lack regulations regarding IO use in the ER as sited in several studies
including a cross-sectional study conducted in Danish EDs. While IO devices are available in the
majority of EDs, guidelines regarding use as well as training are lacking (Molin, 2010). While IO
access is included in the 2010 guidelines for cardiopulmonary resuscitation, there are no national
guidelines available regarding IO access use in sepsis. IO use is currently utilized primarily in
the pre-hospital environment with each organization having their own guidelines usually
Current limitations in the data include that randomized controlled trials are difficult to
obtain as IO use in the ED is limited (Hallas, 2016, P 262). Much of the statistical data obtained,
especially regarding drug and antibiotic administration rates, comes from animal studies as
opposed to human studies for ethical reasons. Another limitation is in regards to limited data
available regarding cost/benefit analysis resulting in the inability to determine overall cost
effectiveness. It should be noted that the cost of IV needles is significantly less than that of IO
EBP Decision
obtaining vascular access for fluid resuscitation in sepsis as well as other shock and hypovolemic
states. The majority of the literature agrees that IO access should be used when obtaining IV or
CVC access is difficult or impossible, or would delay treatment (Lowther, 2011, P 36). It is
IO ACCESS IN SEPTIC PATIENTS 6
recommended that IO access be utilized in septic shock in the ER to ensure that fluid
resuscitation is not delayed and to thereby improve morbidity and mortality rates.
Conceptual Basis
The Nursing Process Discipline Theory developed by Ida Jean Orlando will be used to
guide this project and implementation of best practice in addition to the Plan-Do-Study-Act
model. The theory looks to the nurse to find out and meed the patients immediate needs for
help (Nursing process theory, 2016). Patients are not always able to communicate their needs so
it is the responsibility of the nurse to determine what the patient needs to facilitate improvement
The nurse must be able to assess the patients distress during septic shock in determining
in the best interest of the patient based on the nursing assessment of that patient. It is the function
of the professional nurse to need the patients immediate need, which in this situation is fluid
Procedures
the Quality Improvement committee as well as East Texas Medical Center hospital
administration. At the lower level, approval will need to be sought from the emergency
department director and clinical nurse education as they will be directly involved in coordinating
and supporting this project. This project will be approved by the institutional review board (IRB)
if needed.
IO ACCESS IN SEPTIC PATIENTS 7
Data will be collected from hospital electronic medical records and recorded using
Microsoft Excel Spreadsheet for data reporting and statistical analysis. Data will be collected and
reported as covered by HIPPA for the use in quality improvement purposes. Data gathered will
be protected on the hospitals secure server and no personal patient identifying information will
be recorded.
This project does not require funding by an external service of grant and will be
conducted at minimal expense to the facility. Data regarding cost will be kept as the project is
The Plan-Do-Study-Act (PDSA) will be utilized as the model guiding this project
proposal utilizing the PDSA Worksheet for Testing Change from the Institute for Healthcare
Improvement.
IO ACCESS IN SEPTIC PATIENTS 8
Data will be gathered and statistically analyzed to guide quality improvement regarding
the use of IO access in the ED during septic shock and severe sepsis.
Summary
resuscitation in patients who present in septic shock without current access. In addition to
providing fluid resuscitation, IO access is also an effective route for blood sampling as well as
medication administration with few complications and fast insertion times. Implementation of
use in the ER will benefit patients with decreased mortality rates with data being gathered via
chart reviews and documented and analyzed using Microsoft Excel for continued quality
improvement.
IO ACCESS IN SEPTIC PATIENTS 9
References
Anson, J.A. (2014). Vascular access in resuscitation. Survey of Anesthesiology, 58(6), 319. doi:
10.1097/01.sa.0000455295.73918.19.
Benson, G. (2015). Intraosseous access to the circulatory system: an under-appreciated option for
Cairney, K. & Ibrahim, M. (2012). Options for intravascular access during resuscitation of
Calkins, M.D., Fitzgerald, G., Bentley, T.B., & Burris, D. (2000). Intraosseous infusion devices:
a comparison for potential use in special operations. The Journal of Trauma: Injury,
00012.
Cooper BR, Mahoney PF, Hodgetts TJ, Mellor A. Intra-osseous access (EZ-IO) for resuscitation:
Craiu, M., Stan, I.V., & Cochino, A.V. (2014). Intraosseous access a classical method for
vascular access that regains an important role as resuscitation tool. Revista Romana dr
Day, M.W. (2011). Intraosseous devices for intravascular access in adult trauma patients. Critical
Dubick, M.A. & Holcomb, J.B. (2000). A review of intraosseous vascular access: current status
(18)4: 22-25.
IO ACCESS IN SEPTIC PATIENTS 10
Hallas, P. (2016). Challenges in the use of intraosseous access. Indian Journal of Medical
Joanne, G., Stephen, P., & Susan, S. (2015). Intraosseous vascular access in critically ill adults-a
10.1111/nicc.12163.
Johnson, M., Inaba, K., Byerly, S., Falgraf, E., Lam, L., Benjamin, E., Strumwasser, A., David,
Lewis, P. & Wright, C. (2015). Saving the critically injured trauma patient: a retrospective
doi: 10.1136/eremed-2014-203588.
Leidel, B.A., Kirchhoff, C., Bogner, V., Braunstein, V., Biberthaler, P., & Kanz, K. (2012).
Lowther, A. (2011). Intraosseous access and adults in the emergency department. Nursing
Molin R, Hallas P, Brabrand M, Schmidt TA. Current use of intraosseous infusion in Danish
Med. 2010;18:37
Ngo AS, Oh JJ, Chen Y, Yong D, Ong ME. Intraosseous vascular access in adults using the EZ-
theory.org/theories-and-models/orlando-nursing-process-discipline-theory.php.
Phillips, L. (2011). Recommendations for the use of intaosseous vascular access for emergent
and nonemergent situations in various health care settings: a consensus paper. Journal of
Philips, L., Brown, L., Campbell, T., Miller, J., & Young-berg, B. (2010). Recommendations for
the use of intraosseous vascular access for emergent and nonemergent situations in
various health care settings: a consensus paper. Critical Care Nurse, 30(6), e1-e7. doi:
10.4037/ccn2010632
Sarkar, D. & Philbeck, T. (2009). The use of multiple intraosseous catheters in combat casualty
Strandberg, G., Larsson, A., Lipcsey, M., Michalek, J., & Eriksson, M. (2015). Intraosseous and
10.1111/aaas.12454.
http://survivingsepsis.org/Bundles/Pages/default.aspx.
Vassallo, J., Horne, S., & Smith, J.E. (2014). Journal of Royal Naval Medical Service, 100(1):
36-39.
Von Hoff DD, Kuhn JG, Burris HA, 3rd, Miller LJ. Does intraosseous equal intravenous? A